Arsenal have helped fund Park Theatre’s Reminiscence Group for people with dementia. Stephen Whittle tells us about them ...

We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

1. About lecanemab (generic name, brand name: Leqembi®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...

Professor Nancy Ip discusses her groundbreaking neuroscience research, focusing on neurotrophic factors and innovative ...

A new interdisciplinary study at the University of Delaware seeks to study AD by examining changes in the arteries and brain ...

Wondering what to watch on Apple TV+ next? Here is a list of the best reviewed shows available on Apple’s streaming service.

In 2020, it was estimated that around 9.7 percent of women and 6.9 percent of men in Canada aged 65 years and older were living with dementia. By the year 2050, these figures are expected to ...

Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ in rare pediatric disease HLHS has achieved more than 80% enrollmentPositive Type C ...

Researchers map the unique genetic regulation of proteins in human cerebrospinal fluid, identifying potential targets for ...

This application and the webpage (the “Dementia Directory”) contains information about services (“Information”) provided to Alzheimer’s Society by other organisations (“Information Providers”) for the ...

Dementia researchers have discovered that an amino acid previously thought to boost cognition and memory may actually activate a gene leading to the onset of Alzheimer's. A study, released two ...

An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of Alzheimer’s disease. This patient, like several others in my practice ...